We analyse next generation sequence data to address clinical challenges in a variety of diseases.
The approaches we take include:
- classification of samples into significant subtypes
- identification of driver mutations
- identification of mutational processes that underlie tumour development.
Ultimately, we aim to find alternate therapeutic targets. These are important steps towards ‘personalised medicine’ where the diagnosis, management and treatment of patients will be based on their individual genomic data.
Group Leader: Dr Nic Waddell
- Ann-Marie Patch, Senior Research Officer
- Dr Katia Nones, Senior Research Officer
- Dr Stephen Kazakoff, Research Officer
- Dr Martha Zakrzewski, Research Officer
- Dr Felicity Newell, Senior Research Officer
- Dr Nicole Cloonan, Visiting Scientist
- Bioinformatic tools for the analysis of next generation sequence data
- An integrative bioinformatic approach to the analysis of cancer
If you wish to apply for QIMR Berghofer's student program,
click here for more information.